NCT00114517View on ClinicalTrials.gov

ELITE: Early Versus Late Intervention Trial With Estradiol

PHASE2CompletedINTERVENTIONAL
Enrollment

643

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

February 12, 2013

Study Completion Date

March 5, 2013

Conditions
Atherosclerosis
Interventions
DRUG

17B-estradiol

Oral 17B-estradiol 1 mg daily

OTHER

Placebo

Matching oral 17B-estradiol placebo daily

Trial Locations (1)

90033

Atherosclerosis Research Unit, University of Southern California, Los Angeles

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Southern California

OTHER

NCT00114517 - ELITE: Early Versus Late Intervention Trial With Estradiol | Biotech Hunter | Biotech Hunter